Calcium (Ca 2+ ) and calmodulin (CaM) are required for progression of mammalian cells from quiescence into S phase. In multiple cell types, cyclosporin A causes a G 1 cell cycle arrest, implicating the serine/threonine phosphatase calcineurin as one Ca synthesis. In contrast to the reduction of cyclin D1 with cyclosporin A, ectopic expression of calcium/calmodulin-independent calcineurin promoted synthesis of cyclin D1 during G 1 progression. Therefore, calcineurin is a Ca 2+
Introduction
Calcium (Ca 2+ ) and its major intracellular receptor calmodulin (CaM) are essential for proliferation. During reentry from a quiescent state, mammalian cells required Ca 2+ and CaM during at least two distinct points, in early G 1 and close to the G 1 /S boundary (Boynton et al., 1977; Hazelton et al., 1979; Chafouleas et al., 1984) .
However, neither the crucial relevant downstream cell cycle targets of Ca -binding regulatory subunit, calcineurin B (Klee et al., 1998; Aramburu et al., 2000) . In Aspergillus nidulans, the calcineurin A gene was essential and its disruption led to an early cell cycle arrest (Rasmussen et al., 1994) . When calcineurin A expression was repressed using an inducible promoter, the majority of cells arrested in G 1 , with some cells arrested in G 2 and M phases (Nanthakumar et al., 1996) . In Saccharomyces cerevisiae, none of the three genes encoding calcineurin subunits (CNA1, CNA2/CMP2, and CNB1) were essential (Cyert et al., 1991; Cyert and Thorner, 1992) . However, deletion of the calcineurin subunit genes reduced the ability of cells to recover upon release from α-factor-mediated arrest (Cyert et al., 1991; Cyert and Thorner, 1992; Withee et al., 1997) .
In mammalian systems, calcineurin is well-known for its essential role during the initial activation and proliferation of quiescent T lymphocytes following T cell receptor engagement (Cardenas and Heitman, 1995) . Although the T cell represents a very specialized system of reentry from quiescence, cyclosporin A has antiproliferative effects in a wide variety of cells, including adenocarcinoma cell lines, lymphoma and leukemia cell lines, keratinocytes, fibroblasts, and smooth muscle cells (Furue et al., 1988; Sharpe and Fisher, 1990; Thyberg and Hansson, 1991; Richter et al., 1995; Tomono et al., 1996) .
Where investigated, the cell cycle arrest induced by cyclosporin A was in G 1 although numerous, distinct mechanisms have been proposed. Two recent studies have implicated calcineurin function in the regulation of the transcription, and therefore expression, of both cyclin D and cdk4. While cyclosporin A reduced the levels of cyclin D1 mRNA in pancreatic acinar cells (AR42J), mouse embryonic fibroblasts (MEFs) lacking calcineurin Aα had higher amounts of cdk4 mRNA and protein (Baksh et al., 2002; Schneider et al., 2002) . Taken together, these results suggest that calcineurin function promotes cyclin D1 expression and inhibits cdk4 expression. Since both cyclin D and cdk4 are transcriptionally induced during G 1 , these disparate results initially seem incompatible and may be due to cell type specific differences.
In mammalian cells, D type cyclins act as growth factor sensors, regulate the pathway leading to retinoblastoma protein (pRb) hyperphosphorylation, and are often implicated in oncogenesis (Sherr, 1996; Ortega et al., 2002) . Upon mitogenic stimulation, the D type cyclins accumulate and assemble with cdk4/6 to form active kinase complexes in mid-G 1 , which preferentially phosphorylate pRb.
Hyperphosphorylation of pRb leads to the release of the E2F family of transcription factors, which act to stimulate a number of genes required for S phase (Nevins et al., 1997b) . Therefore, D type cyclins are critical for passage through the restriction point, a defined time in G 1 in which cells become independent of mitogenic stimuli and commit to entry into S. One hypothesis is that to become transformed, human cells must subvert the cyclin D/cdk4/Rb pathway by one of several methods: overexpression of cyclin D1 or cdk4, loss of expression of cdk4 inhibitors (p15/p16 family), or loss of retinoblastoma gene expression (Sherr, 1996) .
Since normal diploid fibroblasts are unlikely to harbor disruptions in either cell cycle or Ca
2+
/CaM-dependent pathways that frequently occur during immortalization and transformation, we have investigated the role of calcineurin during reentry in WI-38 cells.
We found that cyclosporin A arrested WI-38 cells early in G 1 with low levels of cyclin D1 protein similar to the recent results from pancreatic acinar cells (Schneider et al., 2002) . In contrast to that study, we did not observe an effect on the accumulation of cyclin D1 mRNA. translation.
Materials and Methods

Cell Culture and Reagents
WI-38 fibroblasts were obtained from the Coriell Cell Repository (National Institute on Aging, Repository #AG06814F) at passage 14. Cells were grown according to their guidelines in Eagle's MEM with Earle's salts supplemented with MEM nonessential amino acids, MEM vitamins, L-glutamine, and 20% fetal bovine serum (FBS).
For experiments, cells were plated at approximately 5000 cells/cm 2 and grown overnight at 37°C and 5% CO 2 . To arrest cells with low serum, they were washed two times with Puck's solution followed by the addition of media containing 0.2% FBS for 26-32 hours.
To arrest WI-38 cells in mitosis, cells were serum starved as above, serum stimulated for 18 hours, and then, media containing 0.5 µg/ml nocodazole was added for 6 hours. To arrest WI-38 cells in S phase, cells were serum starved as above, serum stimulated for 10 hours, and then, media containing 2 µM hydroxyurea was added for 10 hours.
All cell culture media and supplements were purchased from Gibco-BRL. FBS was obtained from Sigma, Gibco-BRL, or Hyclone, and each time a new lot of serum was used cells were tested to ensure similar growth parameters. Cyclosporin A and MG-132, from Calbiochem, and nocodazole, from Sigma, were dissolved in DMSO. W-13, from RBI/Sigma or Seikagaiku, and hydroxyurea, from Sigma, were dissolved in sterile water.
Flow cytometry and BrdU incorporation
For flow cytometry, 0.5-1.0 x 10 6 cells were trypsinized, pelleted by centrifugation, and resuspended in 200 µl PBS and 800 µl ethanol. Cells were fixed overnight at -20°C and resuspended in 0.5-1.0 ml DNA Prep (Beckman/Coulter). Samples were then washed three times with PBS, incubated with DAPI (5 mg/ml stock) diluted 1:10,000 in PBS for 5 minutes, and mounted under coverslips using a solution of 25 mg/ml triethylenediamine in 50% glycerol and 50% PBS. For each sample, 500-700 cells were counted at random and S phase percentage was determined by dividing the number of BrdU positive nuclei by DAPI positive nuclei.
Assays of Cdk Activity
Cdk2 assays were carried out based on protocols described by DeGregori et. al.
and Sheaff (DeGregori et al., 1995; Sheaff, 1997) . Cells were lysed in Cdk2 IP/RIPA Buffer and protein concentration was determined using DC Protein Assay Kit (Bio-Rad).
For each sample, 500 µg total protein was immunoprecipitated using 2 µg anti-cdk2 (M2, Cdk4 kinase assays were carried out based on protocols described by DeGregori, et. al. and, Phelps and Xiong (DeGregori et al., 1995; Phelps and Xiong, 1997) . Cells were lysed in Cdk4 IP Buffer and protein concentration was determined using DC Protein
Assay Kit (Bio-Rad). For each sample, 500 µg total protein was immunoprecipitated using 2 µg anti-cdk4 (C-22 or H-22, Santa Cruz) and 10 µl Protein A Sepharose 4 Fast Flow (Amersham). The final kinase reaction was carried out in 50 mM HEPES pH 7.5, 10 mM MgCl 2 , 1 mM DTT, 2.5 mM EGTA, 10 mM β-glycerophosphate, 0.1 mM Na 2 VO 4 , 1 mM NaF, 20 µM ATP, 2.5 µCi per reaction of [γ-32 P] ATP (Amersham), and 2 µg per reaction GST-Rb 769-921 (Santa Cruz). Samples were incubated at 30°C for 30 minutes and processed as described above for the cdk2 assays.
Western Analyses
Following lysis in Cdk4 IP buffer, samples were assayed for protein concentration and 50-100 µg of protein (depending on assay) were separated by SDS-PAGE. For most western blots, proteins were separated by 10-12% SDS-PAGE, but for pRb analysis, 6%
SDS-PAGE was used in order to ensure separation of the phosphorylated forms. 
Northern Analysis
Total RNA was extracted from tissue culture cells using Ultraspec RNA (Biotecx Laboratories). Total RNA concentrations were determined and northern analysis was performed as described by Wu and colleagues (Wu, Ribar et al. 2000) . Equal amounts (15 µg) of total RNA were separated by formaldehyde gel electrophoresis and transferred to a Zeta-Probe membrane (Bio-Rad). A 900 bp fragment of the mouse cyclin D1 cDNA was amplified by PCR and randomly labeled with 32 P-dCTP (Amersham Biosciences). .
Northern blots were evaluated by autoradiography and quantified by PhosphorImager analysis. Membranes were routinely stripped and re-probed with GAPDH as a loading control.
Metabolic Labeling
The metabolic labeling of proteins is based on standard protocols for adherent cells (Ausubel 2001; Querido, Blanchette et al. 2001) . Since only Sigma provides Invitrogen, MEME with the usual supplements. Cells were serum stimulated with media lacking methionine/cystine and 20% FBS for 5-6 hours. The media was removed and replaced with a small volume (2.5 ml per 100 mm dish) of MEME without methionine/cystine and containing 35 S EasyTag express protein labeling mix (Perkin Elmer) at a final concentration of ∼0.5 mCi 35 S methionine/cystine mix per 100 mm dish.
Following a two-hour incubation, the labeling media was removed, cells were washed with PBS, and then, lysed in 1 ml Cdk2 IP buffer and frozen with liquid N 2 . For immunoprecipitation, lysates were thawed and cleared by centrifugation. Cleared WI-38 lysate was incubated with 2-4 µg anti-cyclin D1 (M-20, Santa Cruz), and 10-20 µg packed resin for 2-4 hours at 4°C. The resin was washed extensively and proteins separated by SDS-PAGE. The amount of 35 S-labeled cyclin D1 was determined by autoradiography and quantified by PhosphorImager analysis.
Adenoviral Infection of Cells
All adenoviruses were generated using the AdEasy system first described by He and colleagues and now available from Qbiogene (He, Zhou et al. 1998) . The methods used to generate these viruses were based on the initial description of the system, the website with updated protocols and sequence data (http://www.coloncancer.org/adeasy/protocol.htm), and the protocols published by Qbiogene (formerly, Quantum Biotechnologies). WI-38 cells were routinely infected as described by others (DeGregori, Leone et al. 1995; He, Zhou et al. 1998; Cook, Park et al. 2002) . 
Results
Cyclosporin A inhibits cell cycle progression in WI-38 cells
To investigate the effects of cyclosporin A on G 1 progression, we first characterized the cell cycle arrest and release profile of mammalian fibroblasts.
Subconfluent human WI-38 fibroblasts were arrested by serum starvation and stimulated to reenter the cell cycle with the re-addition of serum. Greater than 90% of cells arrest in for early passage WI-38 cells (Brooks-Frederich et al., 1993) .
We next determined the effects of cyclosporin A, a calcineurin inhibitor, and W-13, a CaM antagonist, on cell cycle progression following serum readdition to starved WI-38 cells. Both cyclosporin A and W-13 dramatically reduced the number of cells entering S phase at 18 hours after serum stimulation as shown by the DNA profiles in Figure 2A . These results were confirmed using BrdU incorporation as a measure of DNA synthesis (our unpublished results). Next, we evaluated whether the cyclosporin A induced cell cycle arrest was G 1 selective or if cyclosporin A inhibited progression through other cell cycle phases. WI-38 fibroblasts were arrested in early S phase using hydroxyurea and then, released into fresh media to allow synchronous progression through S and G 2 /M phases. Cyclosporin A had no effect on the ability of cells to progress through S and G 2 /M phases as shown in Figure 2B . Next, we examined whether the cyclosporin A arrest was specific to reentry from growth arrest or also occurred during G 1 following entry from mitosis. WI-38 fibroblasts were arrested in metaphase using nocodazole and then, released into fresh media to allow synchronous progression through mitosis and into G 1 . Whereas cyclosporin A had no effect on the ability of cells to exit mitosis and enter G 1 , it prevented cells from entering S and G 2 /M phases ( Figure   2C ). These results demonstrate that the cyclosporin A arrest is specific to G 1 and that this 
Cyclosporin A prevents pRb phosphorylation by inhibiting cyclin D1 accumulation
To examine the biochemical nature of the cyclosporin A arrest point, we next evaluated the activation status of two G 1 cdk's, cdk2 and cdk4. Cdk2 kinase complexes were immunoprecipitated and assayed for activity using histone H1 as a substrate. In control cells, cdk2 activity appeared by 16 hours after serum addition and was dramatically increased at 20 hours ( Figure 3A ). Cells treated with cyclosporin A demonstrated no cdk2 activity at either 16 or 20 hours. Because there was such little activity, we chose not to evaluate the relative contributions of cyclin E/cdk2 and cyclin A/cdk2 to the total cdk2 activity. Since cdk4 activity is required prior to cdk2 activity during normal G 1 progression, we analyzed cdk4 activity by immunoprecipitating cdk4 kinase complexes followed by kinase assays using GST-Rb as an in vitro substrate.
Although control cells demonstrated cdk4 activity at 18 hours after serum addition, cells treated with cyclosporin A had no activity ( Figure 3B ). As an in vivo monitor of cdk4 activity, we analyzed the phosphorylation status of endogenous pRb protein by western analysis ( Figure 3C A major rate-limiting step in cdk4 activation during G 1 is the accumulation of cyclin D and its expression is strictly dependent on the presence of growth factors (Sherr, 1996) . Although cyclins D1, D2, and D3 form complexes with both cdk4 and cdk6, we examined the most abundant complex in WI-38 cells, cyclin D1 bound to cdk4 (Parry et al., 1999) . In WI-38 cells, cyclosporin A prevented cyclin D1 protein accumulation ( Figure 3D ). Since cyclin D accumulation is tightly controlled at the level of transcription, translation, and ubiquitin-mediated proteolysis, we first examined the level of cyclin D1 mRNA. Whereas serum starved WI-38 cells expressed low levels of cyclin D1 mRNA, it was dramatically induced by 4 hours after serum addition ( Figure 3E ).
Next, we examined cyclin D1 mRNA at 4 hours after serum addition in the presence of cyclosporin A and found similar levels in both treated and untreated cells ( Figure 4F ).
Since cyclin D1 mRNA was upregulated in cyclosporin A treated cells, we concluded that cyclosporin A either prevented efficient translation of cyclin D1 mRNA or accelerated cyclin D1 protein degradation.
Cyclosporin A inhibits the synthesis of cyclin D1
To examine both the synthesis of cyclin D1 and its half-life, we used 35 Smethionine/cystine metabolic labeling of cells, followed by cyclin D1
immunoprecipitation. After a two-hour labeling period in mid-G 1 , we found cyclosporin A treated cells had dramatically less labeled cyclin D1 ( Figure 4A ). This effect appeared selective for cyclin D1 since we found similar labeling of total cell extracts.
Additionally, we detected no reduction in the labeling of cdk4 (our unpublished results), which is also translationally regulated (Ewen et al., 1995) . On average, we found that the amount of labeled cyclin D1 in cells treated with cyclosporin A was about 40% that of untreated cells ( Figure 4B ). In WI-38 cells, the half-life of cyclin D was about 25 minutes, which was similar to the half-life of endogenous cyclin D1 in U2OS cells (Russell et al., 1999) . Although cyclosporin A did not shorten the half-life, we were concerned that the low level of labeled cyclin D1 may affect the half-life determination ( Figure 4C ). One possibility was that cyclin D1 was being rapidly degraded during the two-hour labeling period and that the reduction in cyclin D1 reflected accelerated degradation rather than reduced synthesis during the labeling period. To further evaluate this question, we used a proteasome inhibitor, MG-132, during the labeling period to determine if inhibition of degradation affected the labeling of cyclin D1. As expected, in untreated cells, MG-132 treatment increased the amount of labeled cyclin D1 two-fold ( Figure 4D ). In contrast, MG-132 had little effect on the amount of labeled cyclin D1 in cyclosporin A treated cells. Together, these results implied that cyclosporin A reduced cyclin D1 levels due to decreased translation rather than increased degradation.
Ca 2+ /CaM-independent calcineurin A promotes cyclin D1 synthesis
Although these pharmacological studies suggested a role for calcineurin in cyclin D1 synthesis, we sought to implicate calcineurin more directly. An adenoviral-mediated transgene expression system was chosen to introduce calcineurin and its mutants into WI-38 cells. The primary advantage of this system is the ability of adenovirus to infect nearly 100% cells in a serum-starved condition (Nevins et al., 1997a) . In addition to using wild type calcineurin A, two mutants were used: 1) truncated calcineurin A (1-397) which is Ca 2+ /CaM-independent; and 2) full-length calcineurin A containing the H151Q mutation which is inactive and acts as a dominant negative in some cases (Shibasaki and McKeon, 1995; Mondragon et al., 1997; Sun et al., 1998) . For all three calcineurin A constructs, coinfection with calcineurin B was required for calcineurin A expression ( Figure 5A ). Although we wanted to test if the inactive calcineurin A acted as a dominant negative and mimicked the results of cyclosporin A, we were unable to express calcineurin in serum starved cells and only began to detect expression between 7
and 10 hours after serum addition ( Figure 5B ). Since cyclosporin A did not effectively inhibit reentry when added at 8 hours after serum stimulation, we reasoned it was highly unlikely that the inactive calcineurin A would have any effects due to its delayed and low level expression in G 1 . /CaM-independent calcineurin A, the initial labeling of cyclin D1 was greater than with GFP ( Figure 5C ). The average amount of newly synthesized cyclin D1 in the presence of calcineurin A 1-397 was about 250% that of control samples ( Figure 5D ). Therefore, the effect of Ca (Hojo et al., 1999; Khanna and Hosenpud, 1999) . Second, the cyclosporin A arrest was characterized by a loss of G 1 /S cyclin expression in other cell types (Tomono et al., 1998; Schneider et al., 2002) . In human fibroblasts, we found that cyclosporin A had no effect on p21 levels (our unpublished results) but effectively blocked the accumulation of cyclin D1 protein. Similarly, Schneider and colleagues also found that cyclsoporin A prevented cyclin D1 accumulation in pancreatic acinar cells without any change in p21 levels (Schneider et al., 2002) . In contrast to this cyclosporin A induced reduction in cyclin D1, Tomono and colleagues found normal levels of cyclin D1, but reduced cyclins E and A, in Swiss 3T3 fibroblasts (Tomono et al., 1998; Schneider et al., 2002 (Russell et al., 1999) . If the regulation of cyclin D1 mRNA accumulation and protein degradation is altered in some human tumor cells, it follows that the regulation of cyclin D1 translation may also be perturbed in some tumors.
Whereas cyclosporin A reduced cyclin D1 levels in both pancreatic acinar cells and WI-38 cells, the mechanisms responsible for cyclin D1 reduction are clearly distinct.
In contrast to the result in pancreatic acinar cells in which cyclin D1 mRNA was reduced,
we found no change in the levels of cyclin D1 mRNA between untreated and cyclosporin A treated cells (Schneider et al., 2002) . Rather, using metabolic labeling of endogenous cyclin D1 in WI-38 cells, we show the primary effect of cyclosporin A to be a reduction in the amount of newly synthesized cyclin D1 protein with minimal alteration in the degradation of cyclin D1.
To support our pharmacological studies with cyclosporin A that were suggestive of a role for calcineurin in cyclin D1 translational regulation, we examined the effects of adenoviral expression of calcineurin A mutants (constituitively active, Ca 2+ /CaMindependent or catalytically inactive, "dominant-negative"). As reported previously in other cell types, we found calcineurin A was expressed only when calcineurin B was coexpressed (Shibasaki and McKeon, 1995) . However, none of the calcineurin A constructs were expressed in the serum starved state and protein only began to accumulate several hours after serum stimulation. This result seems to be selective for calcineurin A since we have expressed numerous other adenovirally encoded proteins in WI-38 cells in the serum starved state without difficulty.
Since we could not express the catalytically inactive calcineurin A to high levels in early G 1 , we felt it would be unlikely to act as a "dominant-negative" mimicking the results found with cyclosporin A. On the other hand, we reasoned that even a low expression of constituitively active, Ca Overexpression of eIF-4E stimulated cyclin D1 protein accumulation in the absence of mRNA accumulation in NIH-3T3 cells (Rosenwald et al., 1993) . Whereas the effect eIF-4E on cyclin D1 accumulation was presumed to be specific, eIF-4E regulates the translation of a number of mRNAs, particularly those characterized by long, highly structured, G/C rich 5' UTRs (Gray and Wickens, 1998; McKendrick et al., 1999) .
However, even though cyclin D1 has a G/C rich 5' UTR, no studies to date have examined this region with regard to translational regulation. Although we have not found evidence that cyclosporin A globally affects translation, it is possible that cyclosporin A affects the translation of a subset of mRNAs whose translation is dependent on eIF-4E.
On the other hand, the relationship between eIF-4E and cyclin D1 may be more selective as additional studies have suggested that eIF-4E overexpression augmented the transport of cyclin D1 mRNA from the nucleus to cytoplasmic polysomes (Rosenwald et al., 1993; Rosenwald et al., 1995; Rousseau et al., 1996) .
Another mitogenic signaling pathway that has been reported to regulate cyclin D1 translation is the PI-3K pathway. In MCF10A cells, the initial induction of cyclin D1
protein following mitogenic stimulation began prior to mRNA accumulation (MuiseHelmericks et al., 1998) . This result suggested that cyclin D1 translation was regulated by growth factors independent of its mRNA induction. The authors found that PI-3K
inhibitors prevented cyclin D1 accumulation, and that transfection of activated AKT into serum starved cells prevented the normal down-regulation of cyclin D1 levels. We examined AKT phosphorylation following serum stimulation and found no difference in the induction of AKT phosphosphorylation in cyclosporin A treated and untreated cells, suggesting that the PI-3K and AKT signaling pathway was activated normally in the presence of cyclosporin A (our unpublished results). However, the previous study addressed the block in cyclin D1 accumulation by herbimycin A, an ansamycin antibiotic (Muise-Helmericks et al., 1998) . These antibiotics target the chaperone Hsp90 and therefore, lead to the degradation of a number of proteins, including many protein kinases. Muise-Helmericks and colleagues believe the primary effect of herbimycin A was on the PI-3K/AKT pathway since MEK inhibitors had no effect on cyclin D1 in these cells. However, their results with herbimycin A are interesting since calcineurin activity was stimulated by Hsp90 in vitro and calcineurin A coimmunoprecipitated with Hsp90 from cell extracts (Someren et al., 1999) . Taken hours. Cdk2 complexes were immunoprecipitated from cell lysates followed by an in vitro kinase assay using histone H1 as a substrate. B) Cdk4 IP kinase assays. For cdk4 assays, cells were harvested at 18 hours and then, cdk4 complexes were immunoprecipitated and assayed for activity using GST-pRB CT as a substrate. As a measure of non-specific activity in the immunoprecipitation, extracts were immunoprecipitated in the presence of the cdk4 peptide (used to generate the immunoprecipitating cdk4 antibody) that prevents cdk4 immunoprecipitation and demonstrates minimal activity against the GST-pRB substrate. C) pRB western analysis.
WI-38 lysates were separated by SDS-PAGE and pRB was detected by western blotting.
Hypophosphorylated pRB migrates as a single band, while hyperphosphorylated pRB migrates with a reduced mobility shift. D) Cyclin D1 and cdk4 western analyses. The expression of cyclin D1 and cdk4 were determined at 18 hours after serum addition by western blotting. E) Timecourse of cyclin D1 mRNA accumulation. Equal amounts of total RNA (15 µg) from cells at 1.5 and 4 hours after serum addition were subject to northern analysis using a radiolabeled probe from mouse cyclin D1. F) Cyclin D1 mRNA acummulation with cyclosporin A. Equal amounts of total RNA from cells at 4 hours after serum stimulation, with and without cyclosporin A, were subject to northern analysis for cyclin D1 expression. 
